Zenas BioPharma, Inc. (ZBIO)
25.28
+0.02
(+0.08%)
USD |
NASDAQ |
Mar 06, 16:00
25.32
+0.04
(+0.14%)
After-Hours: 20:00
Zenas BioPharma Shareholders Equity (Quarterly) : 196.43M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Amgen, Inc. | 8.658B |
| Johnson & Johnson | 81.54B |
| Eli Lilly & Co. | 26.54B |
| XOMA Royalty Corp. | 107.96M |
| CorMedix, Inc. | 405.31M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 322.02M |
| Total Liabilities (Quarterly) | 125.59M |
| Debt to Equity Ratio | 0.0041 |
| Current Ratio | 5.659 |
| Net Debt Paydown Yield | -0.01% |